Zobrazeno 1 - 10
of 238
pro vyhledávání: '"Joost L Boormans"'
Autor:
Miriam Angeloni, Thomas vanDoeveren, Sebastian Lindner, Patrick Volland, Jorina Schmelmer, Sebastian Foersch, Christian Matek, Robert Stoehr, Carol I Geppert, Hendrik Heers, Sven Wach, Helge Taubert, Danijel Sikic, Bernd Wullich, Geert JLH vanLeenders, Vasily Zaburdaev, Markus Eckstein, Arndt Hartmann, Joost L Boormans, Fulvia Ferrazzi, Veronika Bahlinger
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 10, Iss 2, Pp n/a-n/a (2024)
Abstract Upper tract urothelial carcinoma (UTUC) is a rare and aggressive, yet understudied, urothelial carcinoma (UC). The more frequent UC of the bladder comprises several molecular subtypes, associated with different targeted therapies and overlap
Externí odkaz:
https://doaj.org/article/ea49233d91ae4f1c9eec6b27ab16c36c
Autor:
J Alfred Witjes, Alina Vrieling, Mihai G Netea, Leo A B Joosten, Katja K H Aben, Sita H Vermeulen, Joost L Boormans, Antoine G van der Heijden, Boris Novakovic, Jelmer H van Puffelen, Liesbeth van Emst, Denise Kooper, Tahlita C M Zuiverloon, Ursula T H Oldenhof, Tessel E Galesloot, Lambertus A L M Kiemeney, Egbert Oosterwijk
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 1 (2023)
Background BCG is recommended as intravesical immunotherapy to reduce the risk of tumor recurrence in patients with non-muscle invasive bladder cancer (NMIBC). Currently, it is unknown whether intravesical BCG application induces trained immunity.Met
Externí odkaz:
https://doaj.org/article/f160d417e5fc4088a9372dbbdff54fa8
Autor:
Lambertus A Kiemeney, Anke Richters, Richard P Meijer, Joost L Boormans, Antoine G van der Heijden, Michiel S van der Heijden, Katja K Aben
Publikováno v:
BMJ Open, Vol 11, Iss 5 (2021)
Introduction A better understanding of the molecular profile of bladder tumours, the identification of novel therapeutic targets, and introduction of new drugs and has renewed research interest in the field of bladder cancer. We describe the design a
Externí odkaz:
https://doaj.org/article/ac0d678092ef478f95460604e0eff0c5
Autor:
Nathalie van den Tempel, Kishan A T Naipal, Anja Raams, Dik C van Gent, Martine Franckena, Joost L Boormans, Roland Kanaar
Publikováno v:
PLoS ONE, Vol 13, Iss 12, p e0209101 (2018)
INTRODUCTION:Bladder cancer (urothelial carcinoma) is a common malignancy characterized by high recurrence rates and intense clinical follow-up, indicating the necessity for more effective therapies. Current treatment regimens include intra-vesical a
Externí odkaz:
https://doaj.org/article/4697288f98cf4b15b8d4af380efc2dc4
Autor:
Kim E M van Kessel, Harmen J G van de Werken, Irene Lurkin, Angelique C J Ziel-van der Made, Ellen C Zwarthoff, Joost L Boormans
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174039 (2017)
BACKGROUND:Neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC) provides a small but significant survival benefit. Nevertheless, controversies on applying NAC remain because the limited benefit must be weight against chemotherapy-
Externí odkaz:
https://doaj.org/article/f421c434fd9243759403dc14b43319f6
Autor:
Maximilian Pallauf, David D’Andrea, Frederik König, Ekaterina Laukhtina, Takafumi Yanagisawa, Morgan Rouprêt, Siamak Daneshmand, Hooman Djaladat, Alireza Ghoreifi, Francesco Soria, Kazutoshi Fujita, Stephen A. Boorjian, Aaron M. Potretzke, Andrea Mari, Mathieu Roumiguié, Alessandro Antonelli, Alberto Bianchi, Zine-Eddine Khene, John P. Sfakianos, Marcus Jamil, Joost L. Boormans, Jay D. Raman, Nico C. Grossmann, Alberto Breda, Axel Heidenreich, Francesco Del Giudice, Nirmish Singla, Shahrokh F. Shariat, Benjamin Pradere
Publikováno v:
Journal of Urology, 209(3), 515-524. Elsevier Inc.
Purpose:Treatment options for the management of upper tract urothelial cancer are based on accurate staging. However, the performance of conventional cross-sectional imaging for clinical lymph node staging (N-staging) remains poorly investigated. Thi
Autor:
A.G. Van Der Heijden, L.A.L.M. Kiemeney, Niven Mehra, Richard P. Meijer, M.S. Van Der Heijden, Anke Richters, Joost L. Boormans, Katja K.H. Aben
Publikováno v:
European Urology Focus, 8, 995-1002
European Urology Focus, 8, 4, pp. 995-1002
European Urology Focus, 8(4), 995-1002. Elsevier
European Urology Focus, 8, 4, pp. 995-1002
European Urology Focus, 8(4), 995-1002. Elsevier
Background: Cisplatin is preferred to carboplatin when treating metastatic urothelial carcinoma of the bladder (mUCB), despite its greater toxicity. Randomised studies underpinning this have been performed in noncontemporary populations with limitati
Autor:
Florus C. de Jong, Teemu D. Laajala, Robert F. Hoedemaeker, Kimberley R. Jordan, Angelique C. J. van der Made, Egbert R. Boevé, Deric K. E. van der Schoot, Bart Nieuwkamer, Emiel A. M. Janssen, Tokameh Mahmoudi, Joost L. Boormans, Dan Theodorescu, James C. Costello, Tahlita C. M. Zuiverloon
Publikováno v:
Science Translational Medicine, 15(697):eabn4118. American Association for the Advancement of Science
The recommended treatment for patients with high-risk non–muscle-invasive bladder cancer (HR-NMIBC) is tumor resection followed by adjuvant Bacillus Calmette-Guérin (BCG) bladder instillations. However, only 50% of patients benefit from this thera
Autor:
Jasmijn Vaneman, Heleen J. van Beekhuizen, Joost L. Boormans, Patricia C. Ewing-Graham, Geert J. L. H. van Leenders, Ramon G. V. Smolders, H C. van Doorn
Publikováno v:
Virchows Archiv. Springer-Verlag
Diagnosis of lymph node metastases in pelvic lymph node dissection (PLND) is important for staging and treatment. Standard practice is to submit visible or palpable lymph nodes for histology. We assessed the added value of embedding all residual fatt
Autor:
Girish S. Kulkarni, Ashish M. Kamat, Edward M. Uchio, Mathieu Roumiguié, Laurence E. M. Krieger, Eric A. Singer, Dean F. Bajorin, Petros Grivas, Ho Kyung Seo, Hiroyuki Nishiyama, Badrinath R. Konety, Ronald de Wit, Ekta Kapadia, Aiwen Xing, Margot Van den Sigtenhorst Fijlstra, Joost L. Boormans
Publikováno v:
Journal of Urology. 209